China Zenith Chemical Group Limited (HKG:0362)
0.0150
-0.0050 (-25.00%)
At close: Mar 17, 2025
HKG:0362 Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| 28.35 | 31.56 | 100.85 | 198.66 | 229.02 | 194.34 | |
Revenue Growth (YoY) | -15.02% | -68.70% | -49.24% | -13.26% | 17.85% | -39.84% |
Selling, General & Admin | 89.88 | 94.32 | 95.56 | 112.23 | 133.55 | 80.25 |
Provision for Bad Debts | 5.88 | 7.27 | -0.16 | -4 | 6.77 | 22.05 |
Other Operating Expenses | 32.82 | 32.22 | 119.99 | 201.84 | 223.88 | 280.34 |
Total Operating Expenses | 128.58 | 133.81 | 215.39 | 310.07 | 364.21 | 382.63 |
Operating Income | -100.23 | -102.24 | -114.54 | -111.41 | -135.18 | -188.3 |
Interest Expense | -89.31 | -92.49 | -113.93 | -166.03 | -126.03 | -110.94 |
Interest Income | 0 | 0 | 0 | 0.03 | 0.95 | 2.04 |
Net Interest Expense | -89.31 | -92.49 | -113.92 | -166 | -125.08 | -108.9 |
Income (Loss) on Equity Investments | - | - | - | -0.14 | 0.27 | -2.02 |
Other Non-Operating Income (Expenses) | 10.56 | 11.07 | -14.99 | -27.47 | -34.99 | - |
EBT Excluding Unusual Items | -178.98 | -183.66 | -243.45 | -305.01 | -294.98 | -299.22 |
Gain (Loss) on Sale of Investments | -1.72 | -1.77 | -0.05 | 1.96 | -2.99 | -2.19 |
Gain (Loss) on Sale of Assets | 98.03 | 87.78 | 404.68 | 8.63 | -4.39 | -1.63 |
Asset Writedown | -65.01 | -65.01 | -359.41 | -4.37 | -1.92 | -62.77 |
Legal Settlements | -17.64 | -16.37 | -2.68 | -2.87 | -62.56 | - |
Other Unusual Items | 11.69 | 8.82 | 14.37 | 40.67 | - | - |
Pretax Income | -153.63 | -170.22 | -186.53 | -261 | -366.85 | -365.81 |
Income Tax Expense | - | - | - | - | 0.89 | - |
Earnings From Continuing Ops. | -153.63 | -170.22 | -186.53 | -261 | -367.74 | -365.81 |
Earnings From Discontinued Ops. | - | - | -8.71 | -812.82 | -91.85 | - |
Net Income to Company | -153.63 | -170.22 | -195.24 | -1,074 | -459.59 | -365.81 |
Minority Interest in Earnings | 9.19 | 7.72 | 39.37 | 9.62 | 9.23 | 10.92 |
Net Income | -144.45 | -162.5 | -155.88 | -1,064 | -450.35 | -354.89 |
Net Income to Common | -144.45 | -162.5 | -155.88 | -1,064 | -450.35 | -354.89 |
Shares Outstanding (Basic) | 1,129 | 720 | 313 | 108 | 72 | 67 |
Shares Outstanding (Diluted) | 1,129 | 720 | 313 | 108 | 72 | 67 |
Shares Change (YoY) | 123.78% | 130.24% | 188.36% | 50.96% | 7.57% | 8.46% |
EPS (Basic) | -0.13 | -0.23 | -0.50 | -9.81 | -6.27 | -5.31 |
EPS (Diluted) | -0.13 | -0.23 | -0.50 | -9.81 | -6.27 | -5.31 |
Free Cash Flow | -18.44 | -8.02 | -18.96 | -69.37 | -79.73 | -16.52 |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.06 | -0.64 | -1.11 | -0.25 |
Profit Margin | -509.47% | -514.86% | -154.57% | -535.68% | -196.64% | -182.61% |
Free Cash Flow Margin | -65.04% | -25.40% | -18.80% | -34.92% | -34.81% | -8.50% |
EBITDA | -74.13 | -69.93 | -58.14 | -38.03 | -62.67 | -119.48 |
EBITDA Margin | -261.47% | -221.57% | -57.65% | -19.14% | -27.36% | -61.48% |
D&A For EBITDA | 26.09 | 32.31 | 56.4 | 73.38 | 72.52 | 68.82 |
EBIT | -100.23 | -102.24 | -114.54 | -111.41 | -135.18 | -188.3 |
EBIT Margin | - | - | -113.58% | -56.08% | -59.03% | -96.89% |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.